HYBRID EVENT: You can participate in person at Rome, Itlay or Virtually from your home or work.

11th Edition of International Conference on

Neurology and Neurological Disorders

June 05-07, 2025 | Rome, Italy

Parkinsonian Disorders

Parkinsonian Disorders

Parkinsonian disorders (PD), also known as Parkinsonism, are a group of neurological conditions characterized by the presence of motor and non-motor symptoms. The primary motor symptoms of PD include tremors, slowness of movement (bradykinesia) and stiffness, as well as limb shaking (rigidity). PD is a progressive disorder; over time, other non-motor symptoms such as changes in cognition, mood, and sensory functioning, may emerge. PD is the most common cause of parkinsonism. It is caused by a loss of neurons producing the neurotransmitter dopamine in a region of the brain called the substantia nigra. When dopamine-producing neurons die, an imbalance occurs in the brain’s glutamate, acetylcholine, and gamma-aminobutyric (GABA) systems. This leads to disruption to the regulation of movement and other processes in the brain, causing the Parkinsonian symptoms. Although there is no cure for PD, various treatments are available to help alleviate the symptoms or slow the progression of the condition. These treatments may include medications, surgical procedures, physical therapy, and lifestyle changes. Medications focus on restoring or substituting for dopamine. Parkinson's drugs, such as levodopa or dopamine agonists, replace lost dopamine. Additionally, drugs that act to increase the amount of available dopamine or improve its efficiency can be used. Surgical procedures like deep brain stimulation and thalamotomy attempt to alleviate symptoms by targeting parts of the brain to correct the dopamine deficiency. Physical therapy can help people with PD by improving their mobility and balance. Other lifestyle changes that may help individuals cope with PD and its symptoms include exercise, diet modification, and stress reduction. Overall, PD is a complex and devastating condition that affects a person's ability to move and affects their day to day life. However, with the right combination of treatments, an individual with PD can live a full and meaningful life.

Committee Members
Speaker at Neurology and Neurological Disorders 2025 - Ken Ware

Ken Ware

NeuroPhysics Therapy Institute, Australia
Speaker at Neurology and Neurological Disorders 2025 - Robert B Slocum

Robert B Slocum

University of Kentucky HealthCare, United States
Speaker at Neurology and Neurological Disorders 2025 - Luiz Moutinho

Luiz Moutinho

University of Suffolk, United Kingdom
Neurology 2025 Speakers
Speaker at Neurology and Neurological Disorders 2025 - David Lominadze

David Lominadze

University of South Florida, United States
Speaker at Neurology and Neurological Disorders 2025 - Milton C R Medeiros

Milton C R Medeiros

Irmandade Santa Casa de Arapongas PR, Brazil
Speaker at Neurology and Neurological Disorders 2025 - Sang Hie Lee

Sang Hie Lee

University of South Florida, United States
Speaker at Neurology and Neurological Disorders 2025 - Sergei M Danilov

Sergei M Danilov

University of Illinois, United States

Submit your abstract Today

Watsapp